Brain, Vol. 124, No. 1, 154-166,
January 2001
© 2001 Oxford University Press
Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis
A correlative study with conventional MRI, histopathology and clinical phenotype
1 Dutch MR Center for MS Research, 2 Departments of Radiology, 3 Pathology and 4 Neurology, Vrije Universiteit Hospital, Amsterdam, 5 Image Sciences Institute, University Medical Centre, Utrecht and 6 Dutch Brain Bank, Amsterdam, The Netherlands
Correspondence to:
Dr G. J. Lycklama à Nijeholt, Department of Radiology, Vrije Universiteit Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands E-mail: g.lycklama{at}azvu.nl
 |
Abstract |
|---|
 Top Abstract IntroductionMaterial and methodsResultsDiscussionReferences |
|---|
We used high-resolution MRI to study the post-mortem appearance of spinal cord multiple sclerosis in relation to histopathology and low-resolution images. Fifty-nine 3 cm long formalin-fixed spinal cord specimens from 19 multiple sclerosis patients and three controls were studied. Clinical characteristics of each patient were reviewed. High-field MRI consisted of proton-density weighted spin-echo imaging with an in-plane resolution of 80 µm. Specimens were also imaged at 1.0 T, with 1 mm pixel resolution. After MRI, the specimens were cut at 5 mm intervals and stained for myelin (Luxol fast blue/cresyl violet) and axons (Bodian method). Two observers scored the MRIs for abnormalities and divided them into (i) well-delineated areas of high signal intensity (SI) and (ii) poorly defined areas of mildly increased SI. Abnormalities were scored semiquantitatively, white matter and grey matter separately. In 81 sections the total area of abnormalities per section was measured on both histopathology sections and on matched high-field MRIs. Abnormalities ranged from just a few abnormal areas to complete involvement of the spinal cord specimen. Patients with an aggressive disease course had more abnormalities than patients with a mild or intermediate disease course. Areas of mildly increased SI were seen in all specimens, and were often found around focal high-SI lesions. However, in six patients, areas of mildly increased SI were the predominant finding on the MRIs, correlating with a primary progressive disease course. Histopathologically, high-SI areas correlated with complete demyelination, while mildly increased SI corresponded with partial demyelination. All areas scored as abnormal by the neuropathologist were also found on the MRIs, and sizes measured using both methods correlated well (r = 0.85, P < 0.01). On conventional MRIs, abnormalities could be recognized fairly well. However, better differentiation could be made between high-SI and mildly increased SI abnormalities on the 4.7 T images. In conclusion, high-resolution MRI revealed a great range of abnormalities in spinal cord multiple sclerosis, which related to disease course during life. Furthermore, we found very good correlation between the extent of abnormalities shown by histopathology and the SI changes on proton-density MRIs, mainly relating to demyelination revealed histopathologically.
multiple sclerosis; MRI; spinal cord; histopathology
AWM = anterior white matter; LWM = lateral white matter; NAWM = normal-appearing white matter; PD = proton density; PP = primary progressive; PWM = posterior white matter; SE = spin echo; SI = signal intensity; SP = secondary progressive; TE = echo time; TR = repetition time
|
Introduction |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsDiscussionReferences |
|---|
MRI studies show that spinal cord abnormalities are found in 80–90% of multiple sclerosis patients (Honig and Sheremata, 1989
; Kidd et al., 1993; Tartaglino et al., 1995; Thorpe et al., 1996) even in the absence of spinal cord symptoms (O'Riordan et al., 1998). On sagittal MRI, focal areas of high signal intensity (SI) are seen in most patients, while on proton density (PD) weighted spin echo (SE) sequences the entire spinal cord may appear diffusely abnormal (Lycklama à Nijeholt et al., 1997). In the axial plane, there is a preponderance of lesions in the lateral and posterior white matter columns (Tartaglino et al., 1995; Thielen et al., 1996). Differences in the appearance of spinal cord abnormalities reflect disease type and symptomatology (Lycklama à Nijeholt et al., 1998). Furthermore, cord atrophy may occur in relation to higher disability (Losseff et al., 1996). Despite the encouraging results of spinal MRI in multiple sclerosis so far, limited spatial resolution and motion artefacts may hinder image interpretation in vivo. As a result, small multiple sclerosis lesions may be missed, and the relationship between multiple sclerosis abnormalities and cord anatomy is difficult to assess. Better knowledge of the histopathological basis of MRI findings would be helpful for the interpretation of in vivo MRI studies in multiple sclerosis. Heterogeneity in MRI findings in spinal cord multiple sclerosis could then be related to histopathology. We used high-resolution MRI to study post-mortem spinal cord specimens of multiple sclerosis patients. The images were compared with corresponding histopathology sections and with MRIs obtained at conventional field strength. Finally, we tested for correlated between spinal MRI findings and clinical findings during life.
|
Material and methods |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsDiscussionReferences |
|---|
The spinal cords of 19 multiple sclerosis patients and three controls (known not to have CNS disease) were obtained at autopsy under the management of the Netherlands Brain Bank. All patients and controls had previously given written approval for the use of their tissue, according to the guidelines of the Netherlands Brain Bank. Specimens (3 cm long) of spinal cord tissue were excised from the cervical, thoracic and lumbar spinal cord. In five patients only two cord specimens were obtained, while in one control only one specimen was obtained. Thus, 59 specimens were acquired, and were fixed in 10% formalin. The post-mortem delay until fixation was 5.5 h at the most.
One neurologist reviewed the clinical history of each patient, using all available hospital charts. Disease duration, the severity of disease and the occurrence of relapses were determined. In addition, the character of the disease course was judged to be aggressive (defined as severe disease resulting in death due to multiple sclerosis in <10 years), intermediate (disease course 10–20 years) or mild (a more prolonged disease course, the patient having died of old age and not from multiple sclerosis). Finally, the type of disease was classified as either secondary progressive (SP) or primary progressive (PP) (Lublin and Reingold, 1996).
All specimens were imaged at 4.7 T. In addition, one specimen from each subject was also studied at conventional field strength (1.0 T), using the same acquisition technique and receiver coil as used for conventional in vivo spinal MRI. As formalin fixation shortens MR relaxation times, PD remaining similar (Carvlin et al., 1989), we optimized our imaging sequence at 4.7 T by varying repetition time (TR) and echo time (TE). Based on these experiments, a combination of long TR and short TE was chosen, resulting in a PD-weighted image contrast, comparable to that obtained in vivo. Contiguous axial slices (1 mm thick) were obtained with an SE sequence [3000/15/10 (TR/TE/NEX) (where NEX = number of excitations)] using a small solenoid receiver coil. In-plane resolution was 80 µm and acquisition time was 1 h. At 1.0 T, axial slices (3 mm) with an interslice gap of 0.3 mm were obtained with a standard SE sequence (2200/14/3), using a spinal phased-array surface coil. In-plane resolution was 1 mm. The specimens were submerged in formalin solution to avoid truncation artefacts in the phase-encoding direction (Curtin et al., 1989). Acquisition time was 10 min.
After completing MRI, all spinal cord specimens were cut transaxially into six pieces, 0.5 cm thick, evenly spaced through the sample. From each tissue block, 8 µm thick histological sections were stained to assess general cellularity (haematoxylin and eosin), myelin (Luxol fast blue/cresyl violet) and axons (Bodian method). They were matched with high-resolution MRIs. A complete autopsy of the brain and spinal cord was performed in all cases, and the clinical diagnosis of multiple sclerosis was confirmed for the multiple sclerosis patients. No abnormalities were found in the control patients.
All high-resolution MRIs of patients and controls were printed out and scored for abnormalities by mutual agreement between two observers. Abnormalities were divided into well-delineated areas of high SI (higher than grey matter) and more poorly defined areas of mildly increased SI [lower than grey matter but higher than normal-appearing white matter (NAWM)]. We scored the anterior (AWM), lateral (LWM) and posterior (PWM) white matter columns separately for both the left and the right side. A semiquantitative scoring system was used: a score of 1 was given if <25% of a particular white matter column was affected; 2 for 25–50% involvement; 3 for >50%; and 4 if the entire column was affected on a particular slice. The grey matter was scored separately (1, <25% affected; 2, 25–50% affected; 3, 50% affected but recognizable; 4, if the grey matter was not recognizable as such). Lesion load per white matter column was calculated as the total score over all slices divided by the highest score possible.
For the 1.0 T MRIs, the number of slices showing increased signal intensity, described for the different white matter columns of the spinal cord, was scored with similar differentiation in high-SI abnormalities and mildly increased SI. However, due to lower spatial resolution, no semiquantitative scale was applied.
In order to study quantitative correlations between high-resolution MRIs and histopathology, a subset of 81 sections, selected from 10 patients to cover a wide range of abnormalities, was analysed as follows. The neuropathologist indicated the borders of abnormal areas on photographs of low-power magnifications (125%) of Luxol fast blue/cresyl violet-stained sections. Abnormalities were categorized as sharply defined areas with no residual staining, or more vaguely delineated areas representing decreased myelin staining. A different observer further quantified the area of all abnormal regions (as indicated on the photographs), using dedicated computer-based, home-developed quantitative pathology software. The matched high-resolution MRIs were quantified by another reader, who was unaware of the histopathological findings, using home-developed local thresholding software. Furthermore, SI was measured in areas of focal high SI, areas of mild SI increase and in NAWM, and the surrounding air (noise). SI measurements were performed in six patients with a large range of abnormalities and in two controls. Measurements were performed on four slices from each subject.
For all comparisons, a paired test for unevenly distributed data was used (Wilcoxon test), while correlations were assessed using Spearman's rank correlation test (r).
|
Results |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsDiscussionReferences |
|---|
Clinical, MRI and histopathological data are summarized in Table 1
. Median age at diagnosis was 37 years (range 23–67 years). Disease duration ranged from 7 to 54 years (median 19 years). In nine patients, the disease course was SP and in seven patients it was PP. In another three patients, a reliable classification could not be made retrospectively.
|
None of the control samples showed abnormalities (Fig. 1
). The PD-weighted MRIs showed good contrast between grey and white matter, and the high spatial resolution enabled visualization of separate white matter columns (Fig. 1). In all multiple sclerosis patients, areas of increased SI were found. Regarding areas of high SI, there was considerable variation in the number of abnormalities between patients (Table 1
). In eight patients, only a few high-SI abnormalities were seen, which extended over only a few slices and involved <25% of the cross-sectional area (Fig. 2). In contrast, in seven patients all slices showed severe high-SI abnormalities, involving the whole cross-sectional area of the cord, rendering the grey matter unrecognizable and deforming the spinal cord contour (Figs 3 and 4). A total of 192 separate lesions were counted in 54 specimens. High-SI lesions were found more frequently in the LWM and PWM than in the AWM (Table 2). The craniocaudal length of the high-SI abnormalities was difficult to assess because in most cases the abnormalities encompassed the entire spinal cord sample. However, 27 of 192 (14%) lesions began and ended within the specimen, thus being <3 cm long.
|
|
|
|
|
Areas of mildly increased SI were seen in all patients, often being found around focal high-SI lesions (Figs 2 and 4
). However, in six patients, areas of mildly increased SI were the predominant finding on MRIs, with only few focal high-SI abnormalities and the central grey matter remaining clearly recognizable (Fig. 5). In the patients, the signal-to-noise ratio in areas of focal high SI was higher (median 57, range 46–141) than in areas of mild SI increase (median 49, range 35–114; P = 0.005).
|
Histopathological examination of specimens from multiple sclerosis patients revealed changes compatible with multiple sclerosis in all patients. In accordance with the high-resolution MRI findings, histopathological abnormalities ranged from only a few abnormalities to complete involvement of all sections examined. Focal areas of high SI, as seen on MRIs, displayed complete demyelination, while on corresponding axon stains a variable degree of axonal loss was found; in some cases no axonal loss was apparent in relation to NAWM in the same section (Figs 2–5
). Areas of mildly increased SI corresponded with areas of partial demyelination. All areas scored as abnormal by the neuropathologist on Luxol fast blue/cresyl violet stains were found as areas of abnormal signal intensity on 4.7 T images, suggesting 100% sensitivity for abnormalities. Also, the total area of abnormalities, as measured on histopathology sections, correlated well with the total area of high-SI abnormalities on 4.7 T images (r = 0.85, P = 0.000; Fig. 6). Nevertheless, the total area of abnormalities on the MRIs (median 52 mm2, range 28–93 mm2) was higher than scored by the neuropathologist (median 44 mm2, range 23–77 mm2; P = 0.000). A review of the discrepancies revealed that this difference was mainly caused by areas of mildly increased SI on MRIs. Such areas were initially not always judged as abnormal by the neuropathologist, and exhibited intermediate staining density on the Luxol fast blue/cresyl violet stains, suggestive of partial demyelination rather than typical, completely demyelinated multiple sclerosis plaques. Correlation of the size of abnormalities seen on MRIs and on neuropathology sections improved when only high-SI MRI abnormalities and typical, completely demyelinated multiple sclerosis plaques were compared (r = 0.94, P = 0.000). While most high-SI plaques were inactive pathologically, some had evidence of active disease, as suggested by the presence of foam cells. On MRIs, no distinction could be made between inactive lesions and lesions showing partial activity. Furthermore, the degree of gliosis was not reflected in differences in MRI appearance. In six patients, mildly increased SI abnormalities were the predominant abnormality (Table 1 and Fig. 5). In these patients, histopathological findings consisted mainly of areas of partial demyelination, while gliosis was scarce. Also, the grey matter remained clearly recognizable. Axonal density in such areas of mild SI increase did not appear different from that in NAWM in the same section (Fig. 5). However, compared with control specimens, there seemed to be some axonal thinning (compare with Fig. 1).
|
MRI examination of patients who suffered an aggressive disease course showed more abnormalities (both high-SI and mildly increased SI) than patients with a mild or intermediate disease course (Fig. 7
). In patients with a disease course suggestive of PP multiple sclerosis, extensive involvement of the spinal cord was seen, but mainly with a mild SI increase and little grey matter involvement, compared with SP patients (Fig. 8). Furthermore, in PP multiple sclerosis patients, the proportion of areas with mildly increased SI in the total amount of abnormalities was higher. In SP patients, a reverse pattern was seen: most abnormal areas consisted of high-SI changes (Table 1).
|
|
No abnormalities were detected in control specimens using 1.0 T images, whereas all spinal cord specimens of multiple sclerosis patients showed abnormalities at 1.0 T. Cross-sectional anatomy could be recognized fairly well on the 1.0 T images in most cases (Figs 1–5
), enabling localization of the abnormalities within white matter columns and/or grey matter. High-SI abnormalities, as seen on 4.7 T images, were also identified on 1.0 T images. However, on 4.7 T images, high-SI and mildly increased SI abnormalities could be better differentiated (Table 3), and larger numbers of the latter type of abnormalities were seen at 4.7 T.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsDiscussionReferences |
|---|
Our study involved a large series of patients and a wide range of abnormalities. The results are in concordance with a previous study concerning the post-mortem MRI appearance of the spinal cord in one patient (Nagao et al., 1994
). We found that the sensitivity of high-resolution MRI was very high when compared with histopathology. In addition, we saw that the amount and type of MRI abnormalities correlated with the clinical course during life, even though they were established in retrospect.
We found typical focal areas of high SI, which represented complete demyelination on histopathology. Such abnormalities extended into the grey matter in many cases, especially in patients with aggressive disease. The morphology, location and shape of such isolated high-SI lesions were comparable to those found in histopathology studies (Fog, 1950; Oppenheimer, 1978); the lesions appeared wedge-shaped and were mostly located in lateral and posterior columns. Apart from well-demarcated, focal high-SI abnormalities, we encountered areas of relatively mild SI increase, corresponding histopathologically with partial demyelination. Such areas were not typically demyelinated multiple sclerosis plaques and the neuropathologist did not recognize all such areas prospectively, resulting in some discrepancy with the MRI findings. However, when the histopathology and MRIs were viewed jointly, all areas of mild SI increase were found to correspond with areas of partial demyelination. This illustrates the usefulness of our MRI protocol as an adjunct to histopathological analysis in relatively subtle abnormalities. On Bodian stains, areas of mild SI change showed only subtle changes compared with the surrounding NAWM; apparently, axonal loss is not the main factor contributing to the signal increase on the corresponding PD-weighted MRIs. However, we did not quantitate axonal density or the amount of myelinated axons. We will now discuss the possible nature of the areas of mild SI increase.
First, we found that the environment of focal multiple sclerosis plaques often showed areas of mildly increased SI. This also corresponds well with the histopathology findings in the brain in multiple sclerosis patients, since the NAWM surrounding multiple sclerosis lesions usually shows subtle abnormalities (Newcombe et al., 1991; Barbosa et al., 1994; Husted et al., 1994; Gasperini et al., 1996). Secondly, a mild SI increase may represent a different pathological process, leading to partial demyelination and extending more diffusely. In our study, PP multiple sclerosis patients especially had areas of mild SI increase, which is in accordance with our in vivo studies (Lycklama à Nijeholt et al., 1997, 1998), in which we found that PP multiple sclerosis patients often had extensive abnormalities in the spinal cord, which consisted of diffuse SI increases on PD-weighted SE images, without focal high-SI lesions. In this study, we found a similar trend, as patients with a PP disease course during life tended to have mainly abnormalities with a mild SI increase. Therefore, we believe that the areas of mild SI increase reported in this study may represent a typical histopathological finding in PP multiple sclerosis, probably reflecting more diffuse and widespread disease activity. This is in accordance with the finding of less perivascular inflammatory activity in lesions of PP multiple sclerosis patients compared with SP multiple sclerosis patients (Revesz et al., 1994). Of course, our findings with regard to the relation between the type of abnormality and the disease course must be interpreted with some caution as there was some overlap, as illustrated by some patients with a slow disease course who did show extensive abnormalities (both high SI and mild increases in SI). This discrepancy may be explained partly by the fact that the disease course was assessed retrospectively. Furthermore, we did not examine the brains of our patients, nor did we examine the spinal cord over its entire length. Imaging the whole CNS post-mortem should theoretically improve the relation between MRI and clinical variables.
Thirdly, an explanation for the occurrence of areas of mild SI increase could be Wallerian degeneration. In our samples, this seemed not to be very likely as Bodian staining revealed only subtle changes, and the areas of mild SI increase were often not continuous throughout the specimen, as would be expected in Wallerian degeneration. Nevertheless, it is conceivable that Wallerian degeneration contributes at least partially to the mild SI changes seen in the spinal cord of multiple sclerosis patients. Quantitative studies of axonal density are warranted in order to resolve this issue, especially in the light of recent studies demonstrating axonal loss in humans with multiple sclerosis (Trapp et al., 1998) and in a murine demyelination model (McGavern et al., 2000). Indeed, a recent study of the axonal density of spinal cord samples of multiple sclerosis patients clearly showed considerable axonal loss, even in NAWM (Lovas et al., 2000).
Our study was limited by the lack of other MRI sequences which may provide a more accurate distinction between mild and severe lesions, such as magnetization transfer imaging (Miki et al., 1999), T1-weighted MRI (Truyen et al., 1996) and diffusion-weighted MRI (Larsson et al., 1992). Indeed, it is well known that conventional PD- or T2-weighted MRI has limited power in detecting lesion heterogeneity. Another limitation in our study was the use of formalin fixation, as it limited us to the use of long-TR, short-TE imaging, as T1 relaxation and MTR (magnetization transfer ratio) are affected by fixation (Carvlin et al., 1989). Furthermore, we did not use quantitative histopathological markers, e.g. the amount of axonal degeneration, which has been found to correlate with T1 prolongation (van Walderveen et al., 1998). Such in-depth studies could further elucidate the nature of the pathological heterogeneity that is described in this study.
In this study, conventional imaging at 1.0 T was sensitive for multiple sclerosis abnormalities, and image contrast between abnormalities and normal spinal cord tissue was generally good. However, it was limited in detecting lesion heterogeneity and exactly localizing abnormalities within the white matter columns and grey matter. Both limitations probably reflect the relatively poor spatial resolution of conventional MRI at present. Hopefully, future MRI developments, such as higher field strength and improvements in receiver coils and gradients, will improve spatial resolution, so that lesion morphology and heterogeneity may be better appreciated in patients during life.
In conclusion, we present the results of a study in which spinal MRI in multiple sclerosis was optimized by increasing spatial resolution. The MRI findings correlated well with histopathological findings, which suggested the differentiation of multiple sclerosis abnormalities into (i) focal high-SI abnormalities representing typical demyelinated plaques, and (ii) less well-defined areas of mildly increased SI representing partial demyelination histopathologically. Since the latter type of abnormality was associated with PP disease, we suggest that such abnormalities may be comparable with the diffuse SI changes observed in vivo. The results of imaging at conventional field strength suggest that, despite its good sensitivity, its main shortcoming is lack of spatial resolution, resulting in limited power to differentiate between several types of abnormality.
|
Acknowledgments |
|---|
We thank Professor Martin of the University of Antwerp for kindly providing control specimens of spinal cord. G.J.L. à N. is funded by the Dutch Foundation for the Support of Multiple Sclerosis Research (grant 92-131).
|
References |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsDiscussionReferences |
|---|
Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RH. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the `invisible' lesion load. Magn Reson Imaging 1994; 12: 33–42.[Web of Science][Medline]
Carvlin MJ, Asato R, Hackney DB, Kassab E, Joseph PM. High-resolution MR of the spinal cord in humans and rats. AJNR Am J Neuroradiol 1989; 10: 13–7.[Abstract]
Curtin AJ, Chakeres DW, Bulas R, Boesel CP, Finneran M, Flint E. MR imaging artifacts of the axial internal anatomy of the cervical spinal cord. AJR Am J Roentgenol 1989; 152: 835–42.
Fog T. Topographic distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol Psychiat 1950; 63: 382–414.
Gasperini C, Horsfield MA, Thorpe JW, Kidd D, Barker GJ, Telfts PS, et al. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. J Magn Reson Imaging 1996; 6: 580–4.[Web of Science][Medline]
Honig LS, Sheremata WA. Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 459–66.
Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 1994; 36: 157–65.[Web of Science][Medline]
Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632–7.
Larsson HB, Thomsen C, Frederiksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992; 10: 7–12.[Web of Science][Medline]
Losseff NA, Webb SL, O'Riordan JI, Page R, Wang R, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701–8.
Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123: 308–17.
Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907–11.
Lycklama à Nijeholt GJ, Barkhof F, Scheltens P, Castelijns JA, Ader H, van Waesberghe JH, et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 1997; 18: 1041–8.[Abstract]
Lycklama à Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998; 121: 687–97.
McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 2000; 123: 519–31.
Miki Y, Grossman RI, Udupa JK, van Buchem MA, Wei L, Phillips MD, et al. Differences between relapsing–remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. Radiology 1999; 210: 769–74.
Nagao M, Ogawa M, Yamauchi H. Postmortem MRI of the spinal cord in multiple sclerosis. Neuroradiology 1994; 36: 625–6.[Web of Science][Medline]
Newcombe J, Hawkins CP, Henderson CL, Patel HA, Woodroofe MN, Hayes GM, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 1991; 114: 1013–23.
O'Riordan JI, Losseff NA, Phatouros C, Thompson AJ, Moseley IF, MacManus DG, et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry 1998; 64: 353–7.
Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 1978; 4: 151–62.[Web of Science][Medline]
Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994; 117: 759–65.
Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995; 195: 725–32.
Thielen KR, Miller GM. Multiple sclerosis of the spinal cord: magnetic resonance appearance. J Comput Assist Tomogr 1996; 20: 434–8.[Web of Science][Medline]
Thorpe JW, Kidd D, Moseley IF, Kendall BE, Thompson AJ, MacManus DG, et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing–remitting multiple sclerosis. Neurology 1996; 46: 373–8.
Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transections in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278–85.
Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW, Polman CH, Hommes OR, et al. Accumulation of hypointense lesions (`black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996; 47: 1469–76.
van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50: 1282–8.
Received May 3, 2000. Revised July 14, 2000. Accepted September 7, 2000.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Rovaris, E. Judica, J. Sastre-Garriga, A. Rovira, M. Pia Sormani, B. Benedetti, T. Korteweg, N. De Stefano, Z. Khaleeli, X. Montalban, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis Multiple Sclerosis, May 1, 2008; 14(4): 455 - 464. [Abstract] [PDF]
|
|
|
|
|
|
J. Zwemmer, J. Bot, B. Jelles, F. Barkhof, and C. Polman At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only Multiple Sclerosis, April 1, 2008; 14(3): 428 - 430. [Abstract] [PDF]
|
|
|
|
|
|
M. Manconi, M.A. Rocca, L. Ferini-Strambi, P. Tortorella, F. Agosta, G. Comi, and M. Filippi Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage Multiple Sclerosis, January 1, 2008; 14(1): 86 - 93. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Agosta, E. Pagani, D. Caputo, and M. Filippi Associations Between Cervical Cord Gray Matter Damage and Disability in Patients With Multiple Sclerosis Arch Neurol, September 1, 2007; 64(9): 1302 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Agosta, M. Absinta, M. P. Sormani, A. Ghezzi, A. Bertolotto, E. Montanari, G. Comi, and M. Filippi In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study Brain, August 1, 2007; 130(8): 2211 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, R Gordon, A J Thompson, and D H Miller Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 51 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Agosta, B. Benedetti, M. A. Rocca, P. Valsasina, M. Rovaris, G. Comi, and M. Filippi Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI Neurology, February 22, 2005; 64(4): 631 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. J. Bot, E. L. A. Blezer, W. Kamphorst, G. J. Lycklama a Nijeholt, H. J. Ader, J. A. Castelijns, K. N. Ig, E. Bergers, R. Ravid, C. Polman, et al. The Spinal Cord in Multiple Sclerosis: Relationship of High-Spatial-Resolution Quantitative MR Imaging Findings to Histopathologic Results Radiology, November 1, 2004; 233(2): 531 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bergers, J.C.J. Bot, C.J.A. De Groot, C.H. Polman, G.J. Lycklama a Nijeholt, J.A. Castelijns, P. van der Valk, and F. Barkhof Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions Neurology, December 10, 2002; 59(11): 1766 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolswijk Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord Brain, February 1, 2002; 125(2): 338 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rovaris, M. Bozzali, G. Santuccio, A. Ghezzi, D. Caputo, E. Montanari, A. Bertolotto, R. Bergamaschi, R. Capra, G. Mancardi, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis Brain, December 1, 2001; 124(12): 2540 - 2549. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||